{"id":"W4411152165","doi":"10.58931/crt.2025.2158","title":"Glucagon-like-peptide 1 (GLP-1) Receptor Agonists in Rheumatologic Disease","year":2025,"lang":"en","type":"article","venue":"Canadian rheumatology today.","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bruyère; Queensway-Carleton Hospital","funders":"","keywords":"Glucagon-like peptide-1; Glucagon-like peptide 1 receptor; Receptor; Exenatide; Glucagon-like peptide-2; Peptide; Medicine; Disease; Glucagon; Endocrinology; Internal medicine; Agonist; Chemistry; Diabetes mellitus; Pharmacology; Biochemistry; Insulin; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001816316,0.0003245627,0.0006974815,0.0009670073,0.0001458855,0.00003515602,0.0002462869,0.0002091417,0.000772381],"category_scores_gemma":[0.0002500711,0.0003153241,0.0001430184,0.0005912232,0.0002054901,0.00008765684,0.0000709759,0.0002478916,0.0007125591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007108132,"about_ca_system_score_gemma":0.001345806,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02653562,"about_ca_topic_score_gemma":0.08477016,"domain_scores_codex":[0.9977859,0.00008483189,0.0004861624,0.0005894923,0.0001286135,0.0009250259],"domain_scores_gemma":[0.9982958,0.0001036416,0.0000770301,0.0006430948,0.00006009218,0.0008202873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001382714,0.0001939752,0.7809247,0.000332938,0.0002764061,0.0006661301,0.0001135906,0.000007472368,0.00001216402,0.04493339,0.1654332,0.006967825],"study_design_scores_gemma":[0.005265092,0.0001525617,0.3213535,0.001393306,0.0002547317,0.00004932275,0.0003821371,0.0003439553,0.00009201159,0.002195406,0.6678969,0.0006210034],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9237092,0.003647759,0.00002346171,0.02155354,0.001480358,0.001105764,0.0000380069,0.0001764831,0.04826541],"genre_scores_gemma":[0.9778754,0.0006695224,0.0002846712,0.003954769,0.000007587134,0.0002433938,0.0002607703,0.00002996015,0.01667397],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5024638,"threshold_uncertainty_score":0.9999299,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007993316232730373,"score_gpt":0.2425667947983174,"score_spread":0.234573478565587,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}